These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses for development of candidate vaccines viruses for pandemic preparedness - February 2011. Wkly Epidemiol Rec; 2011 Mar; 86(11):93-100. PubMed ID: 21395189 [No Abstract] [Full Text] [Related]
17. Development of live attenuated influenza vaccines against pandemic influenza strains. Coelingh KL; Luke CJ; Jin H; Talaat KR Expert Rev Vaccines; 2014 Jul; 13(7):855-71. PubMed ID: 24867587 [TBL] [Abstract][Full Text] [Related]
18. Emerging influenza viruses and the prospect of a universal influenza virus vaccine. Krammer F Biotechnol J; 2015 May; 10(5):690-701. PubMed ID: 25728134 [TBL] [Abstract][Full Text] [Related]
19. Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus. Rudenko L; Isakova-Sivak I Expert Rev Vaccines; 2015 Mar; 14(3):395-412. PubMed ID: 25555687 [TBL] [Abstract][Full Text] [Related]
20. Pandemic preparedness and the Influenza Risk Assessment Tool (IRAT). Cox NJ; Trock SC; Burke SA Curr Top Microbiol Immunol; 2014; 385():119-36. PubMed ID: 25085014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]